| Literature DB >> 22212183 |
Hortencia Silva-Jiménez1, Cristina García-Fontana, Bilge Hilal Cadirci, María Isabel Ramos-González, Juan Luis Ramos, Tino Krell.
Abstract
The two-component system TmoS/TmoT controls the expression of the toluene-4-monooxygenase pathway in Pseudomonas mendocina RK1 via modulation of P(tmoX) activity. The TmoS/TmoT system belongs to the family of TodS/TodT like proteins. The sensor kinase TmoS is a 108 kDa protein composed of seven different domains. Using isothermal titration calorimetry we show that purified TmoS binds a wide range of aromatic compounds with high affinities. Tightest ligand binding was observed for toluene (K(D) = 150 nM), which corresponds to the highest affinity measured between an effector and a sensor kinase. Other compounds with affinities in the nanomolar range include benzene, the 3 xylene isomers, styrene, nitrobenzene or p-chlorotoluene. We demonstrate that only part of the ligands that bind to TmoS increase protein autophosphorylation in vitro and consequently pathway expression in vivo. These compounds are referred to as agonists. Other TmoS ligands, termed antagonists, failed to increase TmoS autophosphorylation, which resulted in their incapacity to stimulate gene expression in vivo. We also show that TmoS saturated with different agonists differs in their autokinase activities. The effector screening of gene expression showed that promoter activity of P(tmoX) and P(todX) (controlled by the TodS/TodT system) is mediated by the same set of 22 compounds. The common structural feature of these compounds is the presence of a single aromatic ring. Among these ligands, toluene was the most potent inducer of both promoter activities. Information on the TmoS/TmoT and TodS/TodT system combined with a sequence analysis of family members permits to identify distinct features that define this protein family.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22212183 PMCID: PMC3815326 DOI: 10.1111/j.1751-7915.2011.00322.x
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 5.813
Figure 1Schematic representation of domain organization and mode of action of phosphorelay two‐component systems. A. The ArcB/ArcA phosphorelay. This system belongs to the TRPR type of phosphorelay according to the classification proposed by Williams and Whitworth (2010). B. The TodS/TodT system that belongs to the TRTR type of phosphorelays. The sequence of phosphoryl group transfer is indicated. tm, transmembrane region; PAS, Per‐Arnt‐Sim type of sensor domain; TR, transmitter module comprised of a dimerization/histidine phosphotransfer domain and a catalytic domain; RRR, response regulator receiver domain; HPT, histidine containing phosphotransfer domain; DNA‐b, DNA‐binding domain.
Figure 2Alignment of operator sites for members of the TodT family.1 Experimentally determined TodT binding sites for P. putida F1 (Lau ) and P. putida DOT‐T1E (Lacal ).2 Experimentally determined StyR sites for P. fluorescens (Leoni ; Rampioni ).3 Proposed StyR binding sites for Pseudomonas sp. strain Y2 (Velasco ).4 Proposed TmoT binding site. The consensus sequence is indicated.
Thermodynamic parameters derived from the microcalorimetric titrations of TmoS with effectors
| Ligand | Effect on TodS | Δ | ||||
|---|---|---|---|---|---|---|
| Benzene | Agonist | (5.96 ± 0.4) 106 | 0.17 ± 0.01 | −5.3 ± 0.1 | 3.6 ± 0.1 | 4.5 |
| Toluene | Agonist | (6.41 ± 0.5) 106 | 0.15 ± 0.01 | −6.5 ± 0.1 | 2.4 ± 0.1 | 4.6 |
| Ethylbenzene | Agonist | (6.39 ± 0.4) 105 | 1.56 ± 0.1 | −3.5 ± 0.1 | 4.1 ± 0.1 | 2.0 |
| Antagonist | (3.48 ± 0.1) 106 | 0.29 ± 0.01 | −8.9 ± 0.1 | −0.3 ± 0.1 | 2.0 | |
| Agonist | (1.41 ± 0.1) 106 | 0.71 ± 0.09 | −7.0 ± 0.8 | 1.1 ± 0.6 | 1.7 | |
| Agonist | (2.17 ± 0.3) 106 | 0.46 ± 0.05 | −3.4 ± 0.3 | 4.9 ± 0.29 | 1.7 | |
| Antagonist | (4.68 ± 0.9) 105 | 2.14 ± 0.4 | −5.1 ± 0.9 | 2.4 ± 0.9 | 0.3 | |
| Agonist | (4.82 ± 0.1) 105 | 2.07 ± 0.6 | −5.9 ± 0.9 | 1.5 ± 0.8 | 4.0 | |
| Agonist | (1.24 ± 0.1) 106 | 0.80 ± 0.09 | −2.7 ± 0.1 | 5.3 ± 0.1 | 0.4 | |
| Chlorobenzene | Agonist | (7.98 ± 0.4) 105 | 1.25 ± 0.07 | −6.9 ± 0.3 | 0.9 ± 0.3 | 1.0 |
| Nitrobenzene | Agonist | (4.32 ± 0.5) 106 | 0.23 ± 0.03 | −4.1 ± 0.1 | 4.5 ± 0.1 | 29.0 |
| Styrene | Agonist | (1.24 ± 0.2) 106 | 0.81 ± 0.1 | −4.8 ± 0.3 | 3.3 ± 0.3 | 0.7 |
| 1,2,4 Trimethylbenzene | Antagonist | (2.89 ± 0.4) 105 | 3.46 ± 0.5 | −1.5 ± 0.2 | 5.6 ± 0.2 | 0.5 |
| cyclohexane | No binding | No binding | ||||
The KD values for the binding of effectors to TodS are taken from Busch and colleagues (2007).
Figure 3Binding of effector molecules to the purified TmoS. Shown are microcalorimetric titrations of 10 µM TmoS with 500 µM benzene (A), toluene (B) and ethylbenzene (C). Injection volumes were 1.6 µl for (B) and 3.2 µl for (A) and (C). Upper panel: titration raw data. Lower panel: Integrated and dilution‐corrected peak areas of raw data. Data were fitted with the ‘One binding site model’ of the MicroCal version of ORIGIN. ▵: benzene; ο: toluene; □, ethylbenzene. The derived thermodynamic parameters are given in Table 1.
Figure 4Autophosphorylation of TmoS in the absence and presence of agonists and antagonists. Assays were conducted as described in Experimental procedures. A. Autophosphorylation of TmoS in the absence and presence of 100 µM effector molecules. Autophophorylation reactions were stopped after 30 min. B. Kinetics of autophosphorylation of TmoS in the presence of 100 µM of the effector molecules indicated. C. Densitometric analysis of data presented in B: ●, toluene; ▴, benzene; , chlorobenzene; grey line: buffer control.
Figure 5Expression from promoters P and P. Shown is a plot of beta‐galactosidase activity of P (y‐axis) against the corresponding value of P (x‐axis) for different compounds. Beta‐galactosidase measurements were carried our as described in Experimental procedures. Note that 1.5 mM of each compound was added to P. putida DOT‐T1E harbouring pMIR77 (P), whereas 0.5 mM of each compound were added to P. mendocina harbouring pMIR38 (P::'lacZ). Expression in the absence of any added compound was found to be 2 ± 1 and 15 ± 4 MU, respectively, for P and P. Shown in this graph are the compounds for which an activity of at least twice the basal rate is observed for both promoters. Compounds, which were analysed but which did not induce any of the promoters, are: 1‐hexanol, cyclohexane, propyl‐, butyl‐ and isopropylbenzene, the 3 trimethylbenzene isomers, 1,2,4 trihydroxybenzene, 1,2,4 trichlorobenzene, o‐xylene, o‐chlorotoluene, the 3 iodotoluene isomers, the 3 nitrotoluene isomers, m‐ethyltoluene, benzenesulfonic acid, benzamide, p‐hydroxybenzaldehyde, p‐toluylaldehyde, 2,3 dimethylphenol, resorcinol, hydroquinone, benzoate, p‐hydroxybenzoate, naphthalene, 1,2,3,4 tetrahydroxynaphthalene. Experiments were means of at least three independent experiments conducted in triplicates. The derived standard deviations are in all cases below 25 % of the mean. Part of the measurements of P activity have been reported in Busch ).
Strains and plasmids used
| Strain/plasmid | Relevant characteristics | Reference |
|---|---|---|
| Strains | ||
| | F‐, | |
| | Prototroph, Tol+ ( | |
| | Prototroph, Tol+ ( | |
| Plasmids | ||
| pMIR77 | TcR, | |
| pMIR38 | TcR, P | |
| pMAX‐47‐2 | GmR, derivative of pBBR1MCS‐5 containing | |
| pET28b | Protein expression plasmid | Novagen |
| pET28b‐TmoS | pET28b containing | This work |
| pET28b‐TmoT | pET28b containing | This work |